Mdna55 Survival In Recurrent Glioblastoma (Rgbm) Patients Expressing The Interleukin-4 Receptor (Il4r) As Compared To A Matched Synthetic Control.

2513Background: MDNA55 is an engineered IL-4 fused to pseudomonas exotoxin A being developed for GBM, an aggressive, universally fatal disease. No curative therapy exists and 75% of patients are no...